glp-1/gip GLP-1 and GIP receptors signal through distinct β-arrestin 2-dependent pathways to regulate pancreatic β cell function The Effects of Dual GLP-1/GIP

A new study suggests heart health gains disappear in half the time it takes to build them up when people stop taking GLP-1 drugs like Ozempic.

GLP-Activate was designed to provide a constant stream of extracts and nutrients that may support healthy GLP-1 levels

Requires medical evaluation and approval by a licensed provider

FDA Enforcement Actions and Safety Concerns In September 2025, the FDA issued over 50 warning letters to compounders marketing GLP-1 products as generic equivalents to FDA-approved drugs

Insurance plans place GLP-1 drugs into different coverage tiers, often requiring prior authorization or high out-of-pocket costs

Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have demonstrated cardiovascular and kidney benefits in the general population with type 2 diabetes mellitus (T2DM), evidence regarding their effects in diabetic KTRs is limited